Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved publishing date : 2021 - 05 - 28 save search
Guardant360® CDx Receives FDA Approval as First and Only Liquid Biopsy Companion Diagnostic for Amgen’s LUMAKRAS™ (sotorasib) KRASG12C Inhibitor for Use in Advanced Non-Small Cell Lung Cancer
Published: 2021-05-28 (Crawled : 21:00) - biospace.com/
GH M | $16.68 1.77% 1.74% 1.6M
|
Health Services
|
| O: 0.82%
H: 2.28%
C: -0.95%
fda lung cancer fda approval cancer approval diagnostic
QIAGEN Launches First FDA-approved Tissue Companion Diagnostic to Identify the KRAS G12C Mutation in NSCLC Tumours and Expand Precision Medicine Options in Lung Cancer
Published: 2021-05-28 (Crawled : 21:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.59%
H: 0.91%
C: -0.14%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.59%
H: 0.91%
C: -0.14%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.38%
H: 1.97%
C: 0.73%
fda lung cancer cancer fda approval diagnostic
Grupo Aeroportuario Del Pacifico Pays Capital Stock Reduction Approved at the General Extraordinary Shareholders’ Meeting
Published: 2021-05-28 (Crawled : 21:00) - globenewswire.com
PAC | $155.9 1.04% 0.0% 33K
|
Transportation
| Email alert
Add to watchlist
approval
BridgeBio Pharma’s Affiliate QED Therapeutics and Partner Helsinn Group Announce FDA Approval of TRUSELTIQ™ (infigratinib) for Patients with Cholangiocarcinoma
Published: 2021-05-28 (Crawled : 19:00) - globenewswire.com
BBIO | $24.98 0.0% 2M
|
Health Technology
| Email alert
Add to watchlist
fda fda approval approval pharma
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-28 (Crawled : 18:31) - fda.gov
ALNY | News | $145.045 -0.19% -0.19% 400K
|
Health Technology
| Email alert
Add to watchlist
REGN | $893.66 -0.84% -0.84% 450K
|
Health Technology
| Email alert
Add to watchlist
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
| Email alert
Add to watchlist
VSTM | $10.19 -6.0% -6.38% 67K
|
Health Technology
| Email alert
Add to watchlist
EXEL | $22.47 -1.75% -1.78% 2.6M
|
Health Technology
| Email alert
Add to watchlist
YMAB | $14.97 -0.93% -0.94% 410K
|
Health Technology
| Email alert
Add to watchlist
KPTI | $1.265 -8.33% -9.09% 1.3M
|
Health Technology
| Email alert
Add to watchlist
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
| Email alert
Add to watchlist
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
| Email alert
Add to watchlist
ILMN | $116.64 -1.4% -1.41% 1.8M
|
Health Technology
| Email alert
Add to watchlist
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
| Email alert
Add to watchlist
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
| Email alert
Add to watchlist
BPMC | News | $88.9 0.59% 0.58% 730K
|
Health Technology
| Email alert
Add to watchlist
CLVS | $0.0812 -3.94%
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
| Email alert
Add to watchlist
ADCT | $4.76 -4.03% 0.0% 280K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
RIGL | $1.06 -4.51% -4.72% 1.2M
|
Health Technology
| Email alert
Add to watchlist
AGIO | News | $29.43 1.38% 1.36% 550K
|
Health Technology
| Email alert
Add to watchlist
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
| Email alert
Add to watchlist
AVEO | $15.0 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
| Email alert
Add to watchlist
cancer approval
FDA Approves First Targeted Therapy for Lung Cancer Mutation Previously Considered Resistant to Drug Therapy
Published: 2021-05-28 (Crawled : 17:00) - prnewswire.com
GH M | $16.68 1.77% 1.74% 1.6M
|
Health Services
|
| O: 0.82%
H: 2.28%
C: -0.95%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.38%
H: 1.97%
C: 0.73%
fda lung cancer therapy cancer drug fda approval approval
FDA Approves LUMAKRAS™ (Sotorasib), The First And Only Targeted Treatment For Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Published: 2021-05-28 (Crawled : 17:00) - prnewswire.com
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 0.41%
H: 2.09%
C: 1.72%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.38%
H: 1.97%
C: 0.73%
treatment fda lung cancer cancer fda approval
FDA Panel Gives Narrow Nod of Approval to Provention's Diabetes Drug
Published: 2021-05-28 (Crawled : 16:00) - biospace.com/
PRVB | $24.98 0.08% 9.1M
|
Health Technology
|
| O: -14.79%
H: 4.4%
C: -16.37%
diabetes fda drug approval
Northern Star Acquisition Corp. Stockholders Approve Proposed Merger With BARK
Published: 2021-05-28 (Crawled : 15:00) - prnewswire.com
SNAP S | $11.63 6.7% 0.09% 54M
|
Technology Services
|
| O: 0.01%
H: 2.58%
C: 1.71%
BOX 4 | $26.47 0.84% -0.87% 1.6M
|
Technology Services
|
| O: 0.09%
H: 3.1%
C: 1.83%
acquisition acquisition corp merge approval
Novo Nordisk resubmits once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes for US regulatory approval
Published: 2021-05-28 (Crawled : 15:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.01%
H: 0.93%
C: 0.11%
diabetes treatment approval
Atlas Corp. Announces Approval for Listing on the Nasdaq Global Market of its 7.125% Senior Unsecured Notes due 2027
Published: 2021-05-28 (Crawled : 13:00) - prnewswire.com
ATCO | $15.48 0.0% 0
|
Finance
|
| O: -0.15%
H: 2.58%
C: 2.21%
approval
Nasdaq Approves High Tide's Application to List
Published: 2021-05-28 (Crawled : 11:00) - prnewswire.com
ACB | $6.555 13.21% 11.67% 8.9M
|
Process Industries
|
| O: 0.67%
H: 6.98%
C: 6.98%
approval application nasdaq
FDA Advisory Committee Votes in Favor of the Benefits of Teplizumab Outweighing the Risks in Support of Approval to Delay Clinical Type 1 Diabetes (T1D)
Published: 2021-05-28 (Crawled : 02:00) - prnewswire.com
PRVB | $24.98 0.08% 9.1M
|
Health Technology
|
| O: -14.79%
H: 4.4%
C: -16.37%
diabetes fda risk approval teplizumab
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.